Revance Therapeutics Inc. (RVNC)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Rankin Officer, Director	$27.82	33,119	$921,211.61	477,565	2020-12-30	Filing
Rankin Officer, Director	$23.85	33,119	$789,888.15	510,684	2020-11-30	Filing
Rankin Officer, Director	$26.15	33,119	$865,949.25	543,803	2020-10-29	Filing
Rankin Officer, Director	$26.18	33,119	$867,055.42	576,922	2020-09-28	Filing
Browne Officer, Director	$15.51	11,613	$180,067.69	151,193	2019-03-18	Filing
Allouche Officer	$15.48	498	$7,709.04	6,400	2019-03-18	Filing
Browne Officer, Director	$17.68	5,446	$96,285.28	168,943	2019-02-19	Filing
Allouche Officer	$17.77	625	$11,106.25	4,000	2019-01-22	Filing
Allouche Officer	$19.48	375	$7,305.00	4,000	2019-01-03	Filing
Allouche Officer	$20.66	491	$10,144.06	4,000	2018-11-20	Filing
Allouche Officer	$23.72	2,188	$51,899.36	4,750	2018-11-09	Filing
Allouche Officer	$28.35	393	$11,141.55	4,750	2018-07-06	Filing
Silvernail Officer	$30.25	2,874	$86,924.42	65,497	2018-05-22	Filing
Silvernail Officer	$30.85	3,431	$105,838.80	68,371	2018-03-22	Filing
Gardner Director	$31.51	5,333	$168,045.50	3,000	2018-03-16	Filing
Browne Officer, Director	$31.43	5,452	$171,347.64	141,875	2018-03-16	Filing
Browne Officer, Director	$32.80	1,000	$32,800.00	130,208	2018-03-15	Filing
Silvernail Officer	$34.50	25,867	$892,411.50	72,954	2018-03-13	Filing
Browne Officer, Director	$31.43	27,283	$857,504.69	131,208	2018-03-07	Filing
Silvernail Officer	$32.50	10,000	$325,000.00	72,954	2018-03-09	Filing